SCHEMBL17768204

SCHEMBL17768204

CC(C)(CO)COc1cccc(NC(=O)N2c3nc(-c4cccc(C(F)(F)F)c4)c(Cl)cc3N3CCC2C3)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPY2R P49146 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ KIT P10721 1/20 0.34
▸ PHGDH O43175 2/20 0.33
▸ FFAR4 Q5NUL3 1/20 0.33
▸ CSNK1E P49674 1/20 0.33
▸ TRPV4 Q9HBA0 3/20 0.33
▸ PTGES O14684 1/20 0.33
▸ KIF18A Q8NI77 3/20 0.33
▸ KCNK3 O14649 1/20 0.32
▸ KCNK9 Q9NPC2 1/20 0.32
▸ SORT1 Q99523 1/20 0.32
▸ TACR2 P21452 1/20 0.32
▸ TACR3 P29371 1/20 0.32
▸ KCNH2 Q12809 1/20 0.32
▸ CACNA1C Q13936 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17778774 1.00 NPY2R (0.36) NPY2RALDH1A1KDM4ECYP2C9HPGD
SCHEMBL17778837 0.93 ALDH1A1 (0.35) NPY2RALDH1A1KDM4ECYP2C9HPGD
SCHEMBL19689804 0.91 ALDH1A1 (0.37) NPY2RALDH1A1KDM4ECYP2C9HPGD
SCHEMBL19689769 0.91 NPY2R (0.35) NPY2RALDH1A1KDM4ECYP2C9HPGD
SCHEMBL17768001 0.90 ALDH1A1 (0.36) NPY2RALDH1A1KDM4ECYP2C9HPGD
SCHEMBL17768197 0.89 KIF18A (0.39) NPY2RALDH1A1KDM4ECYP2C9HPGD
SCHEMBL19689672 0.88 ALDH1A1 (0.35) NPY2RALDH1A1KDM4ECYP2C9HPGD
SCHEMBL19689671 0.88 ALDH1A1 (0.35) NPY2RALDH1A1KDM4ECYP2C9HPGD
SCHEMBL17778530 0.88 ALDH1A1 (0.35) NPY2RALDH1A1KDM4ECYP2C9HPGD
SCHEMBL19706612 0.88 ALDH1A1 (0.35) NPY2RALDH1A1KDM4ECYP2C9HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3221316-A1 SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS Glaxosmithkline Intellectual Property (No. 2) Limited (GB) 2017-09-27 — — EP disclosed
WO-2016079709-A1 SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2016-05-26 — — WO disclosed
Send feedback